News
Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...
Karen Eubanks Jackson has reshaped the conversation around breast cancer for Black women in America—and now, with the ASCO ...
Each year, the American Society of Clinical Oncology annual meeting brings together the biggest names and brightest minds in ...
Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.
Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best ...
The first half of this year has been riddled with market volatility and geopolitical tension. But 2025’s American Society of ...
For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus fluorouracil, leucovorin, ...
At the 2025 ASCO (American Society of Clinical Oncology) Annual Meeting, Dr. Armenian presented findings from the session ...
Leaders in oncology share why the American Society of Clinical Oncology (ASCO) meeting remains a top global gathering for breakthroughs, networking, and lifelong learning.
Pharmaceutical Co. Ltd.’s LYN/BTK dual inhibitor, DZD-8586, saw tumor shrinkage in 94.1% of patients with relapsed or ...
The Trump administration's proposed funding cuts to the National Institutes of Health (NIH), including the National Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results